|
|
Hokkaido University Collection of Scholarly and Academic Papers >
Showing results 1 to 4 of 4
| Type | Author(s) | Title | Other Titles | Citation | Citation(alt) | Issue Date | | article | Cho, Kyu Yong; Nomoto, Hiroshi; Nakamura, Akinobu; Kawata, Shinichiro; Sugawara, Hajime; Takeuchi, Jun; Nagai, So; Tsuchida, Kazuhisa; Omori, Kazuno; Yokoyama, Hiroki; Manda, Naoki; Kurihara, Yoshio; Aoki, Shin; Atsumi, Tatsuya; Miyoshi, Hideaki | Favourable effect of the sodium-glucose co-transporter-2 inhibitor canagliflozin plus the dipeptidyl peptidase-4 inhibitor teneligliptin in combination on glycaemic fluctuation : An open-label, prospective, randomized, parallel-group comparison trial (the CALMER study) | - | Diabetes, Obesity and Metabolism | - | Mar-2020 |
| article | Takahashi, Kiyohiko; Nakamura, Akinobu; Furusawa, Sho; Yokozeki, Kei; Sugawara, Hajime; Yanagisawa, Hideyuki; Akikawa, Kazumasa; Kikuchi, Hideaki | Initial dip predicts renal protective effects after the administration of sodium-glucose cotransporter 2 inhibitors in patients with type 2 diabetes and chronic kidney disease with normoalbuminuria | - | Journal of Clinical and Translational Endocrinology | - | Dec-2020 |
| article | Yamamoto, Chiho; Miyoshi, Hideaki; Ono, Kota; Sugawara, Hajime; Kameda, Reina; Ichiyama, Mei; Yamamoto, Kohei; Nomoto, Hiroshi; Nakamura, Akinobu; Atsumi, Tatsuya | Ipragliflozin effectively reduced visceral fat in Japanese patients with type 2 diabetes under adequate diet therapy | - | Endocrine Journal | - | Jun-2016 |
| article | Nomoto, Hiroshi; Miyoshi, Hideaki; Sugawara, Hajime; Ono, Kota; Yanagiya, Shingo; Oita, Mayuko; Nakamura, Akinobu; Atsumi, Tatsuya | A randomized controlled trial comparing the effects of dapagliflozin and DPP-4 inhibitors on glucose variability and metabolic parameters in patients with type 2 diabetes mellitus on insulin | - | Diabetology & Metabolic Syndrome | - | 17-Jul-2017 |
Showing results 1 to 4 of 4
|
